Hypothesis

Intermittent high-dose dosing of quercetin phytosome produces short-lived lysosomal ROS bursts in senescent adipocytes that exceed the threshold for apoptosis induction, whereas continuous lower-dose isoquercetin fails to achieve this peak despite higher overall AUC.

Rationale

• Quercetin’s senolytic activity in vitro requires 6‑20 μM to trigger mitochondrial permeabilization and caspase‑3 activation【4】.
• Plasma concentrations after phytosome dosing remain in the low‑nanomolar range, but preclinical work shows flavonoid accumulation in lysosomes of hepatocytes and adipocytes, reaching micromolar levels locally【5】.
• The lipid‑based phytosome formulation promotes lymphatic uptake and preferential partitioning into adipose tissue, creating a depot that can release quercetin in pulses upon lipolysis or adipocyte turnover.
• Lysosomal quercetin can redox‑cycle with iron, generating hydroxyl radicals via Fenton chemistry; this ROS burst is sufficient to oxidize cardiolipin and release cytochrome c, activating the intrinsic apoptotic pathway independently of NLRP3 inflammasome signaling.
• Isoquercetin, being more hydrophilic, is absorbed faster but cleared quicker, yielding a flatter plasma curve that does not generate the transient intracellular spikes needed for lysosomal ROS generation.

Testable Predictions

1. In obese human volunteers, a single 500 mg dose of quercetin phytosome will produce a transient (≤2 h) increase in lysosomal quercetin concentration ≥10 μM in subcutaneous adipose biopsies, measured by LC‑MS after subcellular fractionation, while plasma quercetin stays <100 ng/mL.
2. The same dose will correlate with a rise in adipose‑tissue markers of apoptosis (cleaved caspase‑3, TUNEL‑positive cells) and a decline in senescent markers (p16^INK4a, SA‑β‑gal) within 6 h, without sustained elevation of SASP cytokines.
3. A matched regimen of isoquercetin delivering equivalent 24 h AUC will not produce the lysosomal quercetin spike nor the apoptotic signal, despite similar overall exposure.
4. Co‑administration of a lysosomal iron chelator (deferoxamine) will blunt the ROS burst and abrogate the apoptotic response, confirming the mechanistic link.

Falsifiability

If subcellular fractionation shows lysosomal quercetin never exceeds 1 μM after phytosome dosing, or if apoptosis markers do not rise despite detectable lysosomal quercetin, the hypothesis is refuted. Conversely, if isoquercetin produces equivalent lysosomal spikes and apoptosis, the claim of formulation‑dependent transient spikes is false.

Novel Mechanistic Insight

The hypothesis shifts focus from systemic AUC to intracellular compartmentalization: quercetin’s lipophilic nature allows it to hide in lipid droplets and lysosomes, where the acidic milieu and free iron catalyze pro‑oxidant chemistry. Phytosome’s lipid matrix sustains this reservoir, enabling intermittent release that matches the kinetic window required for lysosomal ROS‑driven apoptosis—a window missed by more hydrophilic, rapidly cleared isoquercetin. Furthermore, we propose that the intermittent nature of the spike reduces risk of off‑target antioxidant effects that could blunt senolytic activity at constant low concentrations.